Trivitron Healthcare ties-up with University of Tartu, Estonia

New Delhi, August 21, 2014 : Trivitron Healthcare Pvt. Ltd., India’s biggest medical technology company and The University of Tartu, Estonia has signed a memorandum of understanding, forming the basis of a broad scientific cooperation and furthering of medical education between India and Estonia. The cooperation will mainly be in areas related to mass spectrometry, microchips, sequencing, molecular diagnostics and bio-banking.

Dr. G.S.K. Velu, Founder and Managing Director of Trivitron Healthcare said, “After our acquisition of Labsystems Diagnsotics in Nov 2012, Trivitron is actively pursuing R&D in the new generation IVD techniques like Next Gen Sequencing, Micro Array, Mass Spectrometry and Molecular Diagnostics areas. We found the scientists of University of Tartu had some clear insights in advancement of technologies in this area and hence we have formed an Alliance to cooperate in R&D and Commercialization of products in this area. Apart from this we have identified several areas of R&D Collaboration and Medical Education collaboration with closer India/Finland and Estonia joint initiatives to improve access and affordability for High End Medical Technology initiatives in selected areas of focus. We are sure this will lead to several break through innovations in the focus areas selected by both groups.”

“The University of Tartu holds a leading position in the area of health care and medicine in Estonia and in the Baltic Sea region. The university’s competence and means for innovative research and development activities are the reasons which motivated the major Indian enterprise Trivitron Healthcare to cooperate with the University of Tartu,” said Erik Puura, Vice-Rector for Development of the University of Tartu.

The cooperation will begin after the partners have chosen common topics that are of interest to the researchers while also having commercial potential. “Our aim is to forge contacts between employees with similar interests to exchange the newest knowledge and develop solutions furthering people’s health,” commented Jane Luht, head of technology transfer at the University of Tartu.

The partners will also explore the opportunities to give medical education to the University of Tartu in India, Dubai or Shanghai.

The Rector of the University of Tartu Professor Volli Kalm signed the five-year memorandum of understanding with Gomathy SK Velu, the founder of Trivitron Healthcare Pvt. Ltd. company and the group, on 14 August at 12:00 at the Tallinn office of the University of Tartu. The Ambassador of India Aladiyan Manickam was also present at the signing, as the development of scientific cooperation has been his special interest during his term of office. CCI Newswire